Straits Times Index
3,300.00 -4.00 (-0.12%) S&P 500
5,487.03 +13.80 (+0.25%) Dow
38,834.86 +56.76 (+0.15%) Nasdaq
17,862.23 +5.21 (+0.03%) Bitcoin USD
66,167.48 +996.29 (+1.53%) CMC Crypto 200
1,375.25 -7.41 (-0.54%)
SNY Sep 2024 35.000 put
- Fortune
The secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the next pharma wonder drug
Today we meet with British CEO Paul Hudson to find out how he plans to build the Sanofi of tomorrow.
- Simply Wall St.
Exploring Three Top Dividend Stocks On Euronext Paris
In recent trading sessions, the French stock market has shown resilience, with the CAC 40 Index modestly increasing by 0.11%. This uptick reflects cautious optimism among investors following the European Central Bank's decision to cut interest rates for the first time in five years, signaling a potentially more supportive environment for equities. In this context, dividend stocks can be particularly appealing as they offer potential income in addition to price appreciation opportunities...
- GlobeNewswire
Sanofi: Information concerning the total number of voting rights and shares – May 2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,529,599,938 €Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regi
